Risk of Generalized Vitiligo Is Associated with the Common 55R-94A-247H Variant Haplotype of GZMB (Encoding Granzyme B)  by Ferrara, Tracey M. et al.
Irvine AD, McLean WH, Leung DY (2011) Filag-
grin mutations associated with skin and aller-
gic diseases. N Engl J Med 365:1315–27
Kripke ML (1984) Skin cancer, photoimmunology,
and urocanic acid. Photodermatol 1:161–3
Scott IR, Harding CR, Barrett JG (1982) Histidine-
rich protein of the keratohyalin granules.
Source of the free amino acids, urocanic acid
and pyrrolidone carboxylic acid in the stratum
corneum. Biochim Biophys Acta 719:110–7
Sprecher E, Chavanas S, DiGiovanna JJ et al.
(2001) The spectrum of pathogenic mutations
in SPINK5 in 19 families with Netherton
syndrome: implications for mutation detection
and first case of prenatal diagnosis. J Invest
Dermatol 117:179–87
Thomson ML (1955) Relative efficiency of pigment
and horny layer thickness in protecting the
skin of Europeans and Africans against solar
ultraviolet radiation. J Physiol 127:236–46
Vasilopoulos Y, Sharaf N, di Giovine F et al. (2011)
The 30-UTR AACCins5874 in the stratum
corneum chymotryptic enzyme gene (SCCE/
KLK7), associated with atopic dermatitis;
causes an increased mRNA expression without
altering its stability. J Dermatol Sci 61:131–3
Voegeli R, Rawlings AV, Breternitz M et al. (2009)
Increased stratum corneum serine protease
activity in acute eczematous atopic skin. Br J
Dermatol 161:70–7
Risk of Generalized Vitiligo Is Associated with the
Common 55R-94A-247H Variant Haplotype of GZMB
(Encoding Granzyme B)
Journal of Investigative Dermatology (2013) 133, 1677–1679; doi:10.1038/jid.2013.5; published online 14 February 2013
TO THE EDITOR
In generalized vitiligo (GV), patches of
depigmented skin and overlying hair
(Picardo and Taı¨eb, 2010) result from
autoimmune destruction of melanocytes
by skin-homing autoreactive cytotoxic T
lymphocytes (CTLs) (Ogg et al., 1998).
In two genome-wide association studies
(GWAS) to identify GV susceptibility
loci in European-derived white (EUR)
patients (GWAS1, GWAS2; Jin et al.,
2010, 2012), we detected association
with GZMB, encoding granzyme B, a
serine protease marker of activated CTLs
(Sattar et al., 2003). In concert with
perforin, GZMB mediates direct and
caspase-mediated apoptosis of target
cells (Granville, 2010; Ewen et al.,
2012), as well as proteolytic cleavage
of autoantigens, creating or exposing
autoimmune epitopes that may initiate
or propagate the autoimmune process
(Darrah and Rosen, 2010).
Meta-analysis of GWAS1, GWAS2,
and replication study data for single-
nucleotide polymorphisms (SNPs) geno-
typed in the GZMB region (Jin et al.,
2012) showed greatest association with
rs8192917-C (P¼5.60 109, odds
ratio 1.22), a common nonsynonymous
SNP (R55Q) that is in very strong linkage
disequilibrium with two other common
nonsynonymous SNPs, rs11539752
(P94A; r2¼0.99) and rs2236338
(Y247H; r2¼ 0.93). Together, these
three variants define two predominant
haplotypic multivariant GZMB polypep-
tide isoforms 55Q-94P-247Y (termed
‘‘QPY’’) versus 55R-94A-247H (‘‘RAH’’)
(McIlroy et al., 2003; Zaitsu et al.,
2004). To carry out higher-resolution
analysis of association of GV with
SNPs in the GZMB region, we first
imputed genotypes for all SNPs in the
1,000 Genomes Project phase 1 integra-
ted variant call set (21 June 2012
release) across the 160-kb region
(chr14:25045130–25204958) showing
even nominal association with GV in
the combined GWAS1 and GWAS2
dataset (Jin et al., 2010, 2012), from
101.5 kb upstream of GZMB through
55 kb downstream. After quality control
procedures, there were 464 genotyped
or imputed SNPs in 7,202 total subjects
(Supplementary Table S1 online). In this
analysis, the most significant SNP was
rs10909625 (P¼1.03 108), a synon-
ymous variant at codon K80 (Table 1).
To determine which SNPs in the GZMB
region might be causal for GV suscept-
ibility, we then carried out logistic
regression, individually testing each of
463 SNPs conditional on rs10909625.
This analysis indicated that there is only
one primary association signal in the
GZMB region, represented by nine SNPs
(Table 1) whose effects cannot be dis-
tinguished (Supplementary Table S2
online) owing to very strong linkage
disequilibrium (Supplementary Figure
S1 online). These include rs8192917
(R55Q) and rs11539752 (P94Q); none
of the other seven primary asso-
ciated SNPs (rs6573910, rs6573911,
rs45628336, rs113822535, rs45442494,
rs1126639, and rs10909625) are pre-
dicted to have functional consequences.
In contrast, the associations of
rs2236338 (Y247H), as well as that of
another potentially functional SNP
rs2273844 (stop codon within the 50
untranslated region), were found to be
secondary.
Analysis of the haplotypes defined
by the three nonsynonymous SNPs
rs8192917-rs11539752-rs2236338 simi-
larly indicated that principal association
with GV is with the haplotype compris-
ing rs8192917-C—rs11539752-C. As
shown in Table 2, this constitutes the
higher-risk haplotype (odds ratio 1.27;
P¼4.42108), compared with the
haplotype that also includes the high-
risk G allele of rs2236338 (odds ratio
1.26; P¼3.26107). Nevertheless, it
is difficult to completely exclude anyAccepted article preview online 15 January 2013
Abbreviations: CTL, cytotoxic T lymphocyte; EUR, European-derived white; GV, generalized vitiligo;
GWAS, genome-wide association study; GZMB, granzyme B; SNP, single-nucleotide polymorphism
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effect of rs2236338, as the haplotypes
containing this SNP (C-C-G and C-C-A)
are also associated with elevated risk
for GV.
Genotypes of a number of uncommon
(minor allele frequencyo0.01) poten-
tially functional SNPs in the GZMB
region could not be imputed with high
confidence (MaCH, r2o0.3). To assess
whether the association of GV with
GZMB might result from rare deleterious
variants ‘‘hitchhiking’’ on the most asso-
ciated haplotype of common SNPs, we
carried out next-generation DNA re-
sequencing of a total 8.3 kb across the
GZMB locus, spanning 3.2 kb upstream
of the gene, the five exons, and inter-
vening sequences (with a single 783 nt
gap within intervening sequence 1), to
3.1 kb downstream, in 114 unrelated
EUR GV patients from GWAS1 (Jin
et al., 2010). As shown in Supplementary
Table S3 online, in these 228 alleles,
we observed a total of 41 variants. In
addition to the three aforementioned
common nonsynonymous SNPs, we
observed one additional rare nonsynon-
ymous SNP, rs185979723 (M225L), in a
single heterozygote, predicted to be
functionally benign. There were no
nonsense, frameshift, or splice-junction
mutations, and no indels or other
apparent rearrangements. We also
observed five previously unreported
intergenic and intronic variants, none
of which were of predicted functional
significance. Our findings thus suggest a
major role for the common rs8192917-
C—rs11539752-C-(rs2236338-G) hap-
lotype in genetic association of GZMB
with GV, with no evidence for a major
contribution attributable to rare causal
variants.
Table 1. Association of GV with SNPs in the GZMB region of chromosome 14q12
SNP nt A1 A2
A1
freq
GWAS1,
P
GWAS1,
OR
GWAS2,
P
GWAS2,
OR
CMH,
P
CMH
OR
CMH
L95
CMH
U95 Call type Function
rs2236338 25100282 G A 0.24 4.18 105 1.25 2.96 102 1.20 3.32106 1.23 1.13 1.35 Genotyped Y247H
rs6573910 25100882 T C 0.25 3.15 106 1.28 1.82 102 1.22 1.84107 1.27 1.16 1.38 Imputed
rs6573911 25100933 T C 0.25 3.15 106 1.28 1.82 102 1.22 1.84107 1.27 1.16 1.38 Imputed
rs45628336 25101440 T C 0.24 1.48 106 1.30 1.88 102 1.22 9.69108 1.27 1.17 1.39 Imputed
rs113822535 25101465 T G 0.24 9.11 107 1.30 2.08 102 1.22 6.60108 1.28 1.17 1.40 Imputed
rs45442494 25101475 T G 0.24 6.20 107 1.31 1.84 102 1.22 4.01108 1.28 1.17 1.40 Imputed
rs1126639 25101548 A G 0.24 2.38 106 1.29 2.19 102 1.21 1.74107 1.27 1.16 1.38 Imputed
rs11539752 25101589 C G 0.24 2.98 106 1.29 2.32 102 1.21 2.27107 1.26 1.16 1.38 Imputed P94A
rs10909625 25101629 C T 0.24 9.15 107 1.31 1.22 102 1.24 3.92108 1.28 1.17 1.40 Imputed
rs8192917 25102160 C T 0.25 2.83 106 1.29 2.39 102 1.21 2.25107 1.26 1.16 1.38 Genotyped R55Q
rs2273844 25103414 A G 0.24 4.81 106 1.28 3.00 102 1.20 4.78107 1.26 1.15 1.37 Genotyped Stop
gained
Abbreviations: A1, effect allele (here, high-risk); A2, reference allele; A1 freq, A1 allele frequency in summary 7,202 GV cases and controls; CMH, Cochran–
Mantel–Haenszel meta-analysis; GWAS1, data from 1,388 GV cases and 2,586 controls (Jin et al., 2010); GWAS2, data from 418 GV cases and 2,810 controls
(Jin et al., 2012); GZMB, granzyme B; L95, lower limit of 95% confidence interval; nt, nucleotide position on chromosome 14 (alleles denoted on forward
strand); OR, odds ratio; SNP, single-nucleotide polymorphism; U95, upper limit of 95% confidence interval.
Data are shown for nine genotyped or imputed SNPs (Supplementary Table S1 online) whose effects could not be distinguished by logistic regression analysis,
owing to linkage disequilibrium (Supplementary Table S2 online), as well as for two additional potential functional SNPs, rs2236338 (Y247H) and rs2273844
(stop codon within 50 untranslated region). Note that subject quality control was carried out using the combined GWAS1þGWAS2 data set, and subjects in
GWAS1 who were related to subjects in GWAS2 (pi-hat40.05; 4 GV cases, 43 controls) were removed. The Cochran–Mantel–Haenszel analysis here does not
include replication studies of GWAS1 or GWAS2, which could not be imputed; therefore, P-values shown here for some SNPs are less significant here than
reported in Jin et al., 2012 because of lower sample size.
Table 2. Analysis of haplotypes of GZMB nonsynonymous SNPs rs8192917
(R55Q), rs11539752 (P94A), and rs2236338 (Y247H)
SNP haplotype Amino-acid haplotype F_A F_U P OR
3-SNP haplotypes (rs8192917-rs11539752-rs2236338)
TGA 55Q-94P-227Y 0.716 0.760 1.08E-07 ref
CCG 55R-94A-247H 0.270 0.228 3.26E-07 1.26
CCA 55-R-94A-247Y 0.009 0.005 0.02587 1.69
TGG 55Q-94P-247H 0.006 0.006 0.5314 0.9
2-SNP haplotypes (rs8192917-rs11539752)
TG 55Q-94P 0.7211 0.7663 4.42E-08 ref
CC 55R-94A 0.2789 0.2337 4.42E-08 1.27
Abbreviations: F_A, frequency in cases; F_U, frequency in controls; GZMB, granzyme B; OR, odds
ratio compared with the reference (ref) haplotype; SNP, single-nucleotide polymorphism.
P values compare the frequency of the designated haplotype with all other haplotypes in cases versus
controls.
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The mechanism by which the
GZMB rs8192917-C—rs11539752-C—
(rs2236338-G) haplotype increases GV
risk is not yet known, as functional
correlates of the corresponding 55R-
94A-(247H) and 55Q-94P-(247Y)
GZMB protein variant isoforms remain
uncertain. Individually, the R55Q,
A94P, and Y247H substitutions are each
predicted to be benign (not shown);
however, in silico functional predictions
of individual amino-acid variants are of
unknown validity in the context of such
multivariant haplotypes. We speculate
that the 55R-94A-247H and 55R-94A-
247Y GZMB polypeptides may both
increase the risk of GV, the former
perhaps to a greater degree than the
latter. The GZMB QPY and RAH alleles
exhibit similar expression, stability,
and proteolytic activity of the corre-
sponding alternative GZMB polypeptide
isoforms (McIlroy et al., 2003).
However, there have been conflicting
claims regarding their possible
differential effects on CTL effector
functions. Homozygotes for the
rs8192917-T (55Q) allele have been
reported to express a greater proportion
of GZMB-positive cells after mitogen
stimulation (Girnita et al., 2009),
whereas two studies reported reduced
apoptotic induction by RAH versus QPY
GZMB (McIlroy et al., 2003; Gaafar
et al., 2009), and another found
no difference (Sun et al., 2004).
Regardless, we cannot exclude the alter-
native possibility that the association of
all GZMB-coding variants with GV is
secondary to LD with an as-yet
unidentified causal noncoding SNP.
GZMB has not been genetically asso-
ciated with other autoimmune diseases,
specifically including juvenile idio-
pathic arthritis (Donn et al., 2008) and
Behc¸et’s disease (Kucuksezer et al.,
2009). This suggests the possibility
that GZMB may be relatively specific
for melanocyte-directed autoimmune
susceptibility. In addition to the
effector function of GZMB in target
cell killing by CTLs, perhaps parti-
cularly relevant to GV may be the role
GZMB cleavage has in activating
autoantigens in autoimmune disease
(Darrah and Rosen, 2010). GZMB
cleaves target proteins at aspartic acid
residues (Odake et al., 1991), including
both caspases associated with the
induction of apoptosis and most target
cell autoantigens, potentially enhancing
presentation of cryptic epitopes and
leading to the activation of self-reactive
T cells (Sercarz et al., 1993). GZMB
cleavage sites of GV melanocyte
autoantigens have not yet been defined
experimentally. However, in silico
analysis of the principal human GV
autoantigens using GRASVM 1.0
(Wee et al., 2011) predicts one high-
probability GZMB cleavage site in each
of TYR and TYRP1, three in TYRP2, two
in SOX10, one in PMEL, and none in
MC1R. These findings thus suggest that
in vivo GZMB cleavage of melanocyte
proteins that constitute GV autoantigens
may contribute to the initiation and
propagation of autoimmunity directed
against melanocytes.
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